Recipient age and risk of chronic allograft nephropathy in primary deceased donor kidney transplant

Transplant International

Volumn 19, Issue 8, 2006, Pages 649-656

  Keith, Douglas S ^a,b   Cantarovich, Marcelo ^a   Paraskevas, Steven ^a   Tchervenkov, Jean ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Chronic allograft nephropathy; Death censored graft survival; Deceased donor; Kidney transplant; Recipient age

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; AGING; ARTICLE; CADAVER DONOR; CAUCASIAN; CHILD; CHRONIC ALLOGRAFT NEPHROPATHY; DATA BASE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; KAPLAN MEIER METHOD; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE DIFFERENCE; REGISTER; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DATABASES, FACTUAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; TISSUE DONORS; UNITED STATES;

EID: 33745727564     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00333.x     Document Type: Article

References (32)

1. Meier-Kriesche H, Ojo A, Cibrik D, et al. Relationship of recipient age and the development of chronic allograft failure. Transplantation 2000; 70: 306.
2. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307.
3. 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; Richmond, VA: United Network for Organ Sharing; Ann Arbor, MI: University Renal Research and Education Association.
4. Pirsch JD, Ploeg RJ, Gange S, et al. Determinants of graft survival after renal transplantation. Transplantation 1996; 61: 1581.
5. Stoves J, Newstead CG. Variability of cyclosporine exposure and its relevance to chronic allograft nephropathy: a case-control study. Transplantation 2002; 74: 1794.
6. Sijpkens YW, Doxiadis II, van Kemenade FJ, et al. Chronic rejection with or without transplant vasculopathy. Clin Transplant 2003; 17: 163.
7. Lietz K, Lewandowski Z, Loa M, Paczek L, Gaciong Z. Pretransplant and early posttransplant predictors of chronic allograft nephropathy in cadaveric kidney allograft - a single-center analysis of 1112 cases. Transpl Int 2004; 17: 78.
8. Bradley BA. Rejection and recipient age. Transpl Immunol 2002; 10: 125.
9. Jindel RM, Joseph JT, Morris MC, Santella RN, Baines LS. Noncompliance after kidney transplantation: a systematic review. Transplant Proc 2003; 35: 2868.
10. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: a multicenter study. Transplantation 1998; 66: 1718.
11. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clinical Transplant 1994; 8: 550.
12. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374.
13. Yuge J, Cecka JM. Sex and age effects in renal transplantation. Clinical Transpl 1991: 257.
14. Manjunath G, Sarnak MJ, Levey AS. Estimating the glomerular filtration rate. Dos and don'ts for assessing kidney function. Postgrad Med 2001; 110: 55.
15. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
16. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
17. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857.
18. Humar A, Kerr S, Gillingham KJ, Matas AJ. Features of acute rejection that increase risk for chronic rejection. Transplantation 1999; 68: 1200.
19. Gaston RS, Hudson SL, Ward M, Jones P, Macon R. Late renal allograft loss: noncompliance masquerading as chronic rejection. Transpl Proc 1999; 31: 21S.
20. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071.
21. Guijarro C, Massy ZA, Kasiske BL. Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int Suppl 1995; 52: S56.
22. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004; 78: 557.
23. Bakker RC, Hollander AA, Mallat MJ, Bruijn JA, Paul LC, de Fijter JW. Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy. Kidney Int 2003; 64: 1027.
24. Murphy GJ, Waller JR, Sandford RS, Furness PN, Nicholson ML. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis. Br J Surg 2003; 90: 680.
25. Krieger NR, Becker BN, Heisey DM, et al. Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation 2003; 75: 1677.
26. Chandraker A, Azuma H, Nadeau K, et al. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest 1998; 101: 2309.
27. Laskowski IA, Pratschke J, Wilhelm MJ, et al. Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. J Am Soc Nephrol 2002; 13: 519.
28. Regele H, Bohmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371.
29. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574.
30. Orth SR, Odoni G, Amann K, et al. The ETa receptor blocker LU 135252 prevents chronic transplant nephropathy in the 'Fisher to Lewis model'. J Am Soc Nephrol 1999; 10: 387.
31. Jain S, Furness PN, Nicholson ML. The role of transforming growth factor beta in chronic renal allograft nephropathy. Transplantation 2000; 69: 1759.
32. Akalin E, Dikman S, Murphy B, et al. Glomerular infiltration by CXCR3+ ICOS+ activated T cells in chronic allograft nephropathy with transplant glomerulopathy. Am J Transplant 2003; 3: 1116.